Diabetes care:抗生素是糖尿病足骨髓炎治疗的**

2014-04-01 desperado-c dxy

目前,尚无前瞻性试验研究在糖尿病足骨髓炎患者中比单用抗生素治疗与外科手术治疗。 为此,来自西班牙马德里康普顿斯大学的Lázaro-Martínez教授及其团队进行了一项研究,对单用抗生素治疗和接受保守手术治疗的糖尿病足骨髓炎患者的治疗结局进行比较,并在治愈后对患者进行12周随访。该研究结果发表在2014年03月的Diabetes care杂志上。【原文下载】 该研究是马德里康普顿斯大学

目前,尚无前瞻性试验研究在糖尿病足骨髓炎患者中比单用抗生素治疗与外科手术治疗。

为此,来自西班牙马德里康普顿斯大学的Lázaro-Martínez教授及其团队进行了一项研究,对单用抗生素治疗和接受保守手术治疗的糖尿病足骨髓炎患者的治疗结局进行比较,并在治愈后对患者进行12周随访。该研究结果发表在2014年03月的Diabetes care杂志上。【原文下载】

该研究是马德里康普顿斯大学糖尿病足中心在2010年01月01日至2012年12月31日期间进行的一项前瞻性随机对照试验,受试者为并发骨髓炎的糖尿病神经性足溃疡患者。研究中,受试者被随机分成两组:抗生素组(AG)和手术组(SG)。AG组受试者接受为期90天的抗生素抗感染治疗;而SG组受试者接受保守手术治疗,并在术后进行10天抗生素抗感染治疗。

该研究中,AG组中有18例患者(75%)达到一期愈合,而SG组中有19例患者(86.3%)达到一期愈合。AG组中位愈合时间为7周,而SG组中位愈合时间为6周。AG组中有4例患者病情加重(16.6),并因此进行手术治疗。SG组中有3例患者接受二次手术治疗。两组间的小截肢率没有明显差异。

该研究提示,在并发骨髓炎、但没有局部缺血或坏死性软组织感染的糖尿病神经性足溃疡患者中,抗生素治疗与手术治疗在愈合率、愈合时间、以及短期并发症方面有相似的治疗效果。

这项研究表明,在临床工作中,其实很多糖尿病足骨髓炎患者无需手术,可首先抗生素抗感染治疗,大部分患者病情可获得改善,少数病情没有改善或进一步加重的患者,可以考虑进行手术治疗。

原始出处:

Lázaro-Martínez JL1, Aragón-Sánchez J, García-Morales E.Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial.Diabetes Care. 2014 Mar;37(3):789-95. doi: 10.2337/dc13-1526.【原文下载】


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901193, encodeId=b67719011935f, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 05 03:24:00 CST 2014, time=2014-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636838, encodeId=b39c163683850, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Oct 31 15:24:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759422, encodeId=2fbb1e5942233, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Mar 06 01:24:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952624, encodeId=417d19526246d, content=<a href='/topic/show?id=57bde679650' target=_blank style='color:#2F92EE;'>#糖尿病足骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76796, encryptionId=57bde679650, topicName=糖尿病足骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 28 22:24:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374587, encodeId=fba313e4587d3, content=<a href='/topic/show?id=cade101985bd' target=_blank style='color:#2F92EE;'>#骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101985, encryptionId=cade101985bd, topicName=骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Thu Apr 03 00:24:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901193, encodeId=b67719011935f, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 05 03:24:00 CST 2014, time=2014-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636838, encodeId=b39c163683850, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Oct 31 15:24:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759422, encodeId=2fbb1e5942233, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Mar 06 01:24:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952624, encodeId=417d19526246d, content=<a href='/topic/show?id=57bde679650' target=_blank style='color:#2F92EE;'>#糖尿病足骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76796, encryptionId=57bde679650, topicName=糖尿病足骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 28 22:24:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374587, encodeId=fba313e4587d3, content=<a href='/topic/show?id=cade101985bd' target=_blank style='color:#2F92EE;'>#骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101985, encryptionId=cade101985bd, topicName=骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Thu Apr 03 00:24:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901193, encodeId=b67719011935f, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 05 03:24:00 CST 2014, time=2014-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636838, encodeId=b39c163683850, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Oct 31 15:24:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759422, encodeId=2fbb1e5942233, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Mar 06 01:24:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952624, encodeId=417d19526246d, content=<a href='/topic/show?id=57bde679650' target=_blank style='color:#2F92EE;'>#糖尿病足骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76796, encryptionId=57bde679650, topicName=糖尿病足骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 28 22:24:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374587, encodeId=fba313e4587d3, content=<a href='/topic/show?id=cade101985bd' target=_blank style='color:#2F92EE;'>#骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101985, encryptionId=cade101985bd, topicName=骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Thu Apr 03 00:24:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
    2015-03-06 智智灵药
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901193, encodeId=b67719011935f, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 05 03:24:00 CST 2014, time=2014-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636838, encodeId=b39c163683850, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Oct 31 15:24:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759422, encodeId=2fbb1e5942233, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Mar 06 01:24:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952624, encodeId=417d19526246d, content=<a href='/topic/show?id=57bde679650' target=_blank style='color:#2F92EE;'>#糖尿病足骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76796, encryptionId=57bde679650, topicName=糖尿病足骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 28 22:24:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374587, encodeId=fba313e4587d3, content=<a href='/topic/show?id=cade101985bd' target=_blank style='color:#2F92EE;'>#骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101985, encryptionId=cade101985bd, topicName=骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Thu Apr 03 00:24:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1901193, encodeId=b67719011935f, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 05 03:24:00 CST 2014, time=2014-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636838, encodeId=b39c163683850, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Oct 31 15:24:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759422, encodeId=2fbb1e5942233, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Mar 06 01:24:00 CST 2015, time=2015-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952624, encodeId=417d19526246d, content=<a href='/topic/show?id=57bde679650' target=_blank style='color:#2F92EE;'>#糖尿病足骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76796, encryptionId=57bde679650, topicName=糖尿病足骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Sat Feb 28 22:24:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374587, encodeId=fba313e4587d3, content=<a href='/topic/show?id=cade101985bd' target=_blank style='color:#2F92EE;'>#骨髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101985, encryptionId=cade101985bd, topicName=骨髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Thu Apr 03 00:24:00 CST 2014, time=2014-04-03, status=1, ipAttribution=)]
    2014-04-03 宋威

相关资讯

EASD 2013:糖尿病足患者的院前延迟的影响因素及后期护理质量

来自中国的B. Zhou在9月23日至27日召开的欧洲糖尿病研究学会(EASD)第49届年会上报告,此研究旨在调查糖尿病足患者延迟就医的比例,及可能的危险因素及预后。研究指出,在患者组中存在以下已知因素者长院前延迟最明显:无前期病史、社会经济水平低、足部检查稀少、无随访、从未接受过糖尿病足相关教育及缺乏糖尿病足相关知识;且这些因素所导致的延迟与患者较差的转归、下肢截肢和死亡明显相关。针对危险群体应

哈医大四院开展糖尿病足治疗新技术

  糖尿病足是糖尿病的严重并发症之一。如何降低糖尿病足截肢率,提高治愈率一直是临床探索的难题。近年,哈医大四院内分泌科开展中药外敷、负压吸引联合技术,成功治愈了200余例糖尿病足患者。该技术仅在我省几家大医院开展。   48岁的糖尿病患者血糖升高十余年,近日由于用热水洗脚时双足破溃、水泡,并发展为脓液、红肿。多方辗转来到哈医大四院时,双足背红肿,破溃,溃疡面10×10 cm,大如碗口,已达糖尿病

J Infect Dis:糖尿病患者足部菌群与常人不同

  一项美国研究显示,糖尿病患者足部葡萄球菌属的数量下降,但金黄色葡萄球菌数量仍较多,且细菌多样性较高,可能影响患者伤口的感染风险。论文2013年1月8日在线发表于《感染性疾病杂志》(J Infect Dis)。   该研究对男性门诊患者的4处皮肤(前臂1处,足部3处)进行拭子取样,并对样本分别进行细菌(葡萄球菌、金黄色葡萄球菌)及真菌特异性引物及探针定量聚合酶链式反应(PC

ADA 2013:许樟荣教授认为中国近半非创伤性截肢由糖尿病足所致

    2013年第73届美国糖尿病协会科学年会(ADA2013)于6月21日~25日在美国芝加哥隆重举办。在ADA2013年会上,解放军306医院许樟荣教授发表一篇会议摘要“中国中心城市医院糖尿病截肢和非糖尿病非创伤性截肢患者的临床特点及医疗费用”发表在会议摘要上,研究指出中国42.2%的非创伤性截肢是由糖尿病足导致的。糖尿病截肢患者具有高龄、高血糖、高血压、小截肢

许樟荣:糖尿病足疾病临床研究质量亟待提高

在9月13日召开的2013年中国糖尿病足及相关疾病论坛上,大会执行主席、中华医学会糖尿病学分会糖尿病足与周围血管病学组组长许樟荣教授在大会开幕式上发表主旨演讲时指出,我国的糖尿病足疾病已经越来越受到医务人员的重视,有关论文的发表数量也明显增加。但是临床工作的深入和临床研究质量的提高是迫切需要解决的关键性问题。 许教授指出,糖尿病足是糖尿病的主要慢性并发症之一,糖尿病足

IDSA 2012糖尿病足感染管理指南(可下载)

  近期,美国感染病学会(IDSA)发表感染管理指南指出:对于糖尿病足感染,合理的联合治疗方案能够减少截肢,指南强调了包括专科医师、足病医师、外科医师及骨科组成的多学科综合小组协作的重要。该指南是对IDSA 2004 年指南的回顾与更新,于2012年5月22日在线发表于《临床感染性疾病》(Clinical Infectious Diseases)杂志。   指南推荐